Zoono Group Ltd

Zoono Group operates with a market capitalization of $25.998 million and a price-to-book ratio of 8.09, indicating a premium valuation relative to its book value. The company's equity base of $3.212 million is supported by total assets of $6.335 million, while long-term debt of $587,930 contributes to a debt-to-equity ratio of 0.18. Despite a current ratio of 3.92, the company reported negative operating cash flow of -$1.702 million and free cash flow of -$3.702 million, signaling liquidity constraints. Profitability metrics reveal significant underperformance relative to industry norms. The company reported a net loss of -$3.926 million, with a return on equity of -1.22 and return on assets of -0.62. These figures contrast sharply with the industry_config's preferred metrics for the Personal Products sector, which emphasize gross margin expansion and EBITDA-positive operations. Gross profit of $501,580 on $1.294 million in revenue yields a 38.7% margin, below the median for comparable firms. Geographically, Zoono's revenue is concentrated in Australasia, Asia, the United States, India, the United Kingdom, and Europe, though specific segment allocations are not disclosed. The lack of granular segment reporting limits visibility into regional performance drivers. The company's product portfolio is entirely based on the ZOONO molecule, with no diversification into alternative technologies or markets. Growth expectations are muted, with no disclosed revenue growth in the current fiscal year and no forward-looking guidance provided. The company's historical revenue of $1.294 million shows no year-over-year increase, and no numeric deltas are available for the next fiscal year. This aligns with the risk assessment's "medium" liquidity rating and the "Key flags" warning about negative net cash after debt. The risk profile includes a "medium" liquidity risk and a "low" dilution risk. The company's negative operating cash flow and free cash flow suggest reliance on external financing, though the absence of near-term dilution signals and a low dilution probability indicate limited immediate pressure. No adjustments were applied to the custom valuations, suggesting the financials are presented without material restatements. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company's ongoing losses and negative cash flows suggest a need for operational or strategic changes to achieve profitability.